Enanta Pharmaceuticals, Inc. (ENTA)
13.41
-0.40
(-2.90%)
USD |
NASDAQ |
May 15, 16:00
13.46
+0.06
(+0.41%)
After-Hours: 20:00
Enanta Pharmaceuticals EPS Diluted (Quarterly) : -0.4508 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cyclerion Therapeutics, Inc. | -0.7555 |
| Keros Therapeutics, Inc. | -1.208 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.09M |
| Revenue (Quarterly) | 17.16M |
| Total Expenses (Quarterly) | 30.25M |
| Enterprise Value | 412.78M |
| Gross Profit Margin (Quarterly) | 92.95% |
| Profit Margin (Quarterly) | -76.29% |
| Earnings Yield | -19.35% |
| Normalized Earnings Yield | -19.35 |